Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 14 April 2025, 08:40 HKT/SGT
Share:
Ausnutria Delivers Resilient Dual Growth in Revenue and Profit in 2024
- with Net Profit Increasing by 35.3% and International Business Growing by 68.2%

HONG KONG, Apr 14, 2025 - (ACN Newswire) - On 10 April, Ausnutria Dairy Corporation Ltd (Stock Code: 1717.HK) released its 2024 annual results announcement. According to the announcement, Ausnutria achieved operating revenue of approximately RMB7.402 billion in 2024, a year-on-year (“YoY”) growth of 0.3% and profit attributable to equity holders of the parent company of approximately RMB236 million, a YoY growth of 35.3%, realizing a resilient dual growth in revenue and profit. It is worth mentioning that Ausnutria's international business has entered the fast lane with a significant YoY growth of 68.2%, which has become a new growth driver.

According to the announcement, in 2024, in the face of the internal and external economic situation of the world's economic growth momentum and insufficient effective domestic demand, Ausnutria steadily promoted the “milk powder + nutrition products” nutrition strategy for the whole family and further strengthened its leading position as the “World’s No.1 goat milk powder brand”. Through multi-dimensional measures such as strengthening scientific innovation, expanding market, enhancing efficiency and consolidating foundation, Ausnutria has maintained its market share against the backdrop of the overall shrinking infant formula market, realizing revenue growth with a significant increase in profit, thereby surpassing the industry cycle with resilient growth.  

In terms of segmentation, Ausnutria's own brand milk powder business segment achieved an overall revenue of approximately RMB5.806 billion, of which the goat milk powder business realized revenue of approximately RMB3.699 billion, representing a YoY increase of 12.7%, while the cow milk powder business realized revenue of approximately RMB2.107 billion. The nutrition products business segment realized revenue of approximately RMB305 million, representing a YoY increase of 7.1%. 

In terms of region, in 2024, the goat milk powder business of the PRC recorded revenue of approximately RMB3,053 million, representing a YoY growth of 5.3%, while the goat milk powder international business realized revenue of approximately RMB647 million, representing a significant YoY growth of 68.2%, which maintained a high growth trend. The share of total revenue from the Company's own brand formula goat milk powder business further increased to 17.5%.

According to the announcement, the Middle East region has continued to show solid growth momentum in 2024; the CIS market achieved high double-digit growth; and a milestone breakthrough was achieved in the first year of the launch of Kabrita’s goat IMF in the U.S. market. Through the dual-track strategy of “online precise promotion + offline channel expansion”, Kabrita quickly grabbed the top category seller on the Amazon platform and was awarded the “Best Goat Milk Baby Formula Product” in the US. Ausnutria said in the announcement that with more and more medical professionals and professional organizations further recognizing the value of goat milk, North America is expected to become another strategic growth pole after the Middle East.




Topic: Press release summary Sectors: Exchanges & Software, Food & Beverage
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Fullerton Health Deepens Specialty Care Capabilities Through Acquisition of Singapore-Based Otolaryngology Practice, The ENT Clinic  
Jan 7, 2026 10:30 HKT/SGT
Mitsubishi Motors to Celebrate "Delica Festival" with Custom Versions of Delica D:5 and Delica Mini at Tokyo Auto Salon 2026  
Wednesday, January 7, 2026 7:59:00 AM
Mitsubishi Motors Launches the Xforce in Taiwan  
Wednesday, January 7, 2026 7:52:00 AM
"> Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China
  
Wednesday, January 7, 2026 7:43:00 AM
Radisson Announces Additional High-Grade Drill Results and Further Extends New Mineralization Beneath the Historic O'Brien Gold Mine  
Jan 6, 2026 20:00 HKT/SGT
Hong Kong Toys & Games Fair leads market innovation, debut 'Pop & Play' pavilion opens to industry and public  
Jan 6, 2026 18:50 HKT/SGT
CTF Life Amplifies Ecosystem Synergy  
Jan 6, 2026 15:35 HKT/SGT
Asian Financial Forum kicks off 2026 as region's first major event of 2026  
Jan 6, 2026 04:41 HKT/SGT
Notice on the Establishment of a Special Subsidiary  
Jan 5, 2026 21:00 HKT/SGT
TANAKA Announces Executive Appointment  
Jan 5, 2026 21:00 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: